Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allograft immune response with sCR1 intervention

J R Pratt1, M J Hibbs, A J Laver

  • 1Department of Renal Medicine, Guy's Hospital, London, UK.

Transplant Immunology
|March 1, 1996
PubMed
Summary

Complement inhibition using soluble complement receptor 1 (sCR1) reduced inflammation and injury in rat kidney transplants. This suggests complement plays a key role in allograft rejection by activating immune cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultralow Loss Torsion Micropendula for Chipscale Gravimetry.

Physical review letters·2025
Same author

Bridging classical and quantum mechanics.

Metrologia·2020
Same author

Invited Article: A precise instrument to determine the Planck constant, and the future kilogram.

The Review of scientific instruments·2016
Same author

A simple, cost-effective multispecies toxicity test using organisms with a cosmopolitan distribution.

Environmental monitoring and assessment·2013
Same author

The functional responses of two benthic algivorous ciliated protozoa with differing feeding strategies.

Microbial ecology·2013
Same author

Chronocoulometry for quantitative control of mass removal in micro-structures and sensors.

The Review of scientific instruments·2012

Area of Science:

  • Immunology
  • Transplantation Biology
  • Complement System

Background:

  • Complement (C) deposition on transplanted organs can trigger inflammatory responses.
  • The precise role of complement activation in allograft rejection remains unclear.

Purpose of the Study:

  • To investigate the role of complement activation in allograft rejection.
  • To evaluate the efficacy of complement inhibition using recombinant human soluble complement receptor 1 (sCR1) in a rat renal allograft model.

Main Methods:

  • Utilized a Lewis to DA rat renal allograft model with fully MHC disparate recipients.
  • Administered daily doses of sCR1 (25 mg/kg) or saline (control) to allograft recipients.
  • Assessed histopathology, complement deposition (C3, C5b-9 MAC), and leukocyte antigen markers from day 1 to 5 post-transplant.

Related Experiment Videos

Main Results:

  • sCR1 treatment led to reduced vascular injury and cellular infiltration in allografts.
  • Complement deposition (C3 and C5b-9 MAC) was significantly decreased in sCR1-treated animals.
  • Flow cytometry revealed fewer activated B and T cells in the spleen of sCR1-treated rats.

Conclusions:

  • Complement inhibition with sCR1 effectively suppressed vascular and cell-mediated tissue injury in a rat renal allograft model.
  • These findings highlight a significant role for complement in mediating allograft rejection, influencing both antibody and cell-mediated cytotoxicity.
  • The data suggest complement activation is involved in the primary immune response, leading to T and B cell activation during allograft rejection.